Paradigm Biopharmaceuticals Ltd. (ASX: PAR) Announces Key Achievements in Quarterly Report
Paradigm Biopharmaceuticals announces key achievements in its December 2024 quarterly activities, including successful FDA protocol clearance and financial highlights.